Dishman Carbogen Amcis allots ₹38 crore non-convertible debentures (NCDs)
Dishman Carbogen Amcis (DCAL) said it has allotted non-convertible debentures (NCDs) of ₹38 crore. The company is valued at about ₹2,387 crore.
What happened
In a filing with the BSE on 15 October 2026 at 01:11 PM, Dishman Carbogen Amcis (DCAL) said that it has allotted non-convertible debentures (NCDs) of ₹38 crore.
How big is it?
At ₹38 crore, the issue is equal to about 1.6% of the company's market value of ₹2,387 crore.
Company snapshot
Dishman Carbogen Amcis is a small-cap company, with a market value of about ₹2,387 crore.
The stock last traded at ₹152.2, against a 52-week range of ₹128.5–₹303 (49.8% below the high).
Before this filing the shares had moved −10.0% over the month and −22.4% over three months. Average daily turnover over the last 20 sessions was about ₹2.87 crore.
Promoters held 59.32% at the end of Q1 FY27. Foreign institutions owned 6.86% and domestic institutions 2.07%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 708 | 23.4 | 1.49 |
| Q2 FY26 | 653 | 65.3 | 4.16 |
| Q3 FY26 | 720 | -13 | -0.83 |
| Q4 FY26 | 851 | 21.7 | 1.39 |
| Q1 FY27 | 678 | -57.9 | -3.69 |
What history shows
BCEIE's records show 4 previous fund raising filings from the company since May 2026.
After those filings, the stock fell 4.7% on average the next trading day and was down 10.2% on average after five days (4 filings with price data).
Market-wide, 1,582 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 28 Sept 2026 | Herewith Intimation of allotment of NCDs. | −4.0% | −9.9% |
| 17 Aug 2026 | Fund raising | −11.3% | −9.1% |
| 12 Aug 2026 | Board Meeting Outcome for Board Meeting Outcome For BOARD APPROVES… | +2.6% | −10.9% |
| 9 Jun 2026 | Fund raising | −6.1% | −10.7% |
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.